SCHEMBL22003254

SCHEMBL22003254

CCN(CC)CCNC(=O)CCC(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
GAA P10253 1/20 0.43
CYP3A4 P08684 1/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
DNM1 Q05193 1/20 0.41
SLC22A1 O15245 2/20 0.41
LMNA P02545 3/20 0.41
KMT2A Q03164 2/20 0.41
ACHE P22303 2/20 0.41
SLC22A2 O15244 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
MEN1 O00255 1/20 0.40
CNR1 P21554 1/20 0.40
BLM P54132 1/20 0.40
PMP22 Q01453 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3287403 0.87 DNM1 (0.51) CYP1A2CYP2D6GAACYP3A4DNM1
SCHEMBL24225247 0.83 ALDH1A1 (0.46) ALDH1A1GAAHPGDDNM1LMNA
SCHEMBL13407923 0.81 SMN1; SMN2 (0.46) ALDH1A1CYP1A2CYP2D6GAACYP3A4
SCHEMBL15468358 0.81 CASP2 (0.53) ALDH1A1CYP1A2CYP2D6GAACYP3A4
SCHEMBL11441214 0.81 CASP2 (0.46) ALDH1A1HPGDDNM1LMNAKMT2A
SCHEMBL14548967 0.80 ALDH1A1 (0.43) ALDH1A1GAAKDM4EHPGDDNM1
SCHEMBL20622920 0.80 ALDH1A1 (0.50) ALDH1A1HPGDDNM1LMNAACHE
SCHEMBL24626058 0.79 CYP1A2 (0.46) ALDH1A1CYP1A2CYP2D6GAACYP3A4
SCHEMBL3288269 0.79 DNM1 (0.53) ALDH1A1GAADNM1LMNACNR1
SCHEMBL1518045 0.79 ALDH1A1 (0.57) ALDH1A1GAAHPGDDNM1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200155692-A1 DENDRIMER DRUG CONJUGATES FOR SUSTAINED INTRA-ARTICULAR DELIVERY UNITED STATES GOVERNMENT 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200155692-A1 DENDRIMER DRUG CONJUGATES FOR SUSTAINED INTRA-ARTICULAR DELIVERY CD44, ITGA6, ITGA2B ALDH1A1 980/4885CYP1A2 4329/4885CYP2D6 1673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.